Lian-Xiang Luo (Lianxiang Luo, Lian Xiang Luo)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 47

Top Topics

Molecular Docking

Top Venues

Molecules (Basel, Switzerland)

Oxidative medicine and cellular longevity

Clinical and experimental medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Xuexuan Wu, Saiyi Zhong, Nan Zhou, Lian-Xiang Luo
TRAF6 Inhibitors from Marine Compound Library: Pharmacophore, Virtual Screening, Fragment Replacement, ADMET, and Molecular Dynamics. Marine drugs 22 (6) (2024)
Jiaqi Chen, Xuan Li, Jiahua Tao, Lian-Xiang Luo
Identification of Marine-Derived SLC7A11 Inhibitors: Molecular Docking, Structure-Based Virtual Screening, Cytotoxicity Prediction, and Molecular Dynamics Simulation. Marine drugs 22 (8) (2024)
Nan Zhou, Chuangze Zheng, Huiting Tan, Lian-Xiang Luo
Identification of PLK1-PBD Inhibitors from the Library of Marine Natural Products: 3D QSAR Pharmacophore, ADMET, Scaffold Hopping, Molecular Docking, and Molecular Dynamics Study. Marine drugs 22 (2) (2024)
Yongyi Liang, Shaojun Qiu, Youwen Zou, Elaine Lai-Han Leung, Lian-Xiang Luo
Ferroptosis-Modulating Natural Products for Targeting Inflammation-Related Diseases: Challenges and Opportunities in Manipulating Redox Signaling. Antioxidants & redox signaling (2024)
Jiaqi Chen, Xuan Li, Jiahua Tao, Lian-Xiang Luo
Identification of Marine-Derived SLC7A11 Inhibitors: Molecular Docking, Structure-Based Virtual Screening, Cytotoxicity Prediction, and Molecular Dynamics Simulation. Marine drugs 22 (8) (2024)
Nan Zhou, Chuangze Zheng, Huiting Tan, Lian-Xiang Luo
Identification of PLK1-PBD Inhibitors from the Library of Marine Natural Products: 3D QSAR Pharmacophore, ADMET, Scaffold Hopping, Molecular Docking, and Molecular Dynamics Study. Marine drugs 22 (2) (2024)
Nan Zhou, Chuangze Zheng, Huiting Tan, Lian-Xiang Luo
Identification of PLK1-PBD Inhibitors from the Library of Marine Natural Products: 3D QSAR Pharmacophore, ADMET, Scaffold Hopping, Molecular Docking, and Molecular Dynamics Study. Marine drugs 22 (2) (2024)
Nan Zhou, Chuangze Zheng, Huiting Tan, Lian-Xiang Luo
Identification of PLK1-PBD Inhibitors from the Library of Marine Natural Products: 3D QSAR Pharmacophore, ADMET, Scaffold Hopping, Molecular Docking, and Molecular Dynamics Study. Marine drugs 22 (2) (2024)
Xuexuan Wu, Saiyi Zhong, Nan Zhou, Lian-Xiang Luo
TRAF6 Inhibitors from Marine Compound Library: Pharmacophore, Virtual Screening, Fragment Replacement, ADMET, and Molecular Dynamics. Marine drugs 22 (6) (2024)
Xuexuan Wu, Saiyi Zhong, Nan Zhou, Lian-Xiang Luo
TRAF6 Inhibitors from Marine Compound Library: Pharmacophore, Virtual Screening, Fragment Replacement, ADMET, and Molecular Dynamics. Marine drugs 22 (6) (2024)
Jiaqi Chen, Xuan Li, Jiahua Tao, Lian-Xiang Luo
Identification of Marine-Derived SLC7A11 Inhibitors: Molecular Docking, Structure-Based Virtual Screening, Cytotoxicity Prediction, and Molecular Dynamics Simulation. Marine drugs 22 (8) (2024)
Huiting Tan, Chenying Li, Tianli Lai, Lian-Xiang Luo
In Silico Analysis of USP7 Inhibitors Based on Building QSAR Models and Fragment Design for Screening Marine Compound Libraries. Marine drugs 22 (1) (2023)
Liyan Deng, Shasha He, Ying Li, Rui Ding, Xiaoling Li, Nuoqing Guo, Lian-Xiang Luo
Identification of Lipocalin 2 as a Potential Ferroptosis-related Gene in Ulcerative Colitis. Inflammatory bowel diseases (2023)
Fangfang Wang, Meng Zhang, Meng Yuan, Zixuan Xia, Fengge Yang, Sihao Zhang, Tengyu Lin, Lian-Xiang Luo, Jinshan Tang, Youwei Zhang
A novel sorbicillinoid compound as a potent anti-inflammation agent through inducing NLRP3 protein degradation. British journal of pharmacology (2023)
Fangfang Wang, Meng Zhang, Meng Yuan, Zixuan Xia, Fengge Yang, Sihao Zhang, Tengyu Lin, Lian-Xiang Luo, Jinshan Tang, Youwei Zhang
A novel sorbicillinoid compound as a potent anti-inflammation agent through inducing NLRP3 protein degradation. British journal of pharmacology (2023)
Lian-Xiang Luo, Liyan Deng, Yongtong Chen, Rui Ding, Xiaoling Li
Identification of Lipocalin 2 as a Ferroptosis-Related Key Gene Associated with Hypoxic-Ischemic Brain Damage via STAT3/NF-κB Signaling Pathway. Antioxidants (Basel, Switzerland) 12 (1) (2023)
Qiqi Huang, Tianli Lai, Qu Wang, Lian-Xiang Luo
mPGES-1 Inhibitor Discovery Based on Computer-Aided Screening: Pharmacophore Models, Molecular Docking, ADMET, and MD Simulations. Molecules (Basel, Switzerland) 28 (16) (2023)
Lin-Fang Zhong, Juan Ling, Lian-Xiang Luo, Chang-Nian Yang, Xiao Liang, Shu-Hua Qi
Lecanicilliums A-F, Thiodiketopiperazine-Class Alkaloids from a Mangrove Sediment-Derived Fungus Lecanicillium kalimantanense . Marine drugs 21 (11) (2023)
Huiting Tan, Chenying Li, Tianli Lai, Lian-Xiang Luo
In Silico Analysis of USP7 Inhibitors Based on Building QSAR Models and Fragment Design for Screening Marine Compound Libraries. Marine drugs 22 (1) (2023)
Lian-Xiang Luo, Liyan Deng, Yongtong Chen, Rui Ding, Xiaoling Li
Identification of Lipocalin 2 as a Ferroptosis-Related Key Gene Associated with Hypoxic-Ischemic Brain Damage via STAT3/NF-κB Signaling Pathway. Antioxidants (Basel, Switzerland) 12 (1) (2023)
Yushi Zheng, Shanshan Wu, Xueshan Huang, Lian-Xiang Luo
Ferroptosis-Related lncRNAs Act as Novel Prognostic Biomarkers in the Gastric Adenocarcinoma Microenvironment, Immunotherapy, and Chemotherapy. Oxidative medicine and cellular longevity 2023 (2023)
Huiting Tan, Chenying Li, Tianli Lai, Lian-Xiang Luo
In Silico Analysis of USP7 Inhibitors Based on Building QSAR Models and Fragment Design for Screening Marine Compound Libraries. Marine drugs 22 (1) (2023)
Lian-Xiang Luo, Huiting Tan, Yinglin Liao
In silico analysis of marine natural product for protein arginine methyltransferase 5(PRMT5) inhibitors based on pharmacophore and molecular docking. Journal of biomolecular structure & dynamics (2023)
Rui Li, Qing-Ling Zhou, Shu-Tong Chen, Min-Rui Tai, Hong-Ying Cai, Rui Ding, Xiao-Fei Liu, Jian-Ping Chen, Lian-Xiang Luo, Sai-Yi Zhong
Chemical Characterization and Immunomodulatory Activity of Fucoidan from Sargassum hemiphyllum . Marine drugs 21 (1) (2022)
Cheng-Mei Liu, Fei-Hua Yao, Xin-Hua Lu, Xue-Xia Zhang, Lian-Xiang Luo, Xiao Liang, Shu-Hua Qi
Isoquinoline Alkaloids as Protein Tyrosine Phosphatase Inhibitors from a Deep-Sea-Derived Fungus Aspergillus puniceus . Marine drugs 20 (1) (2022)
Lian-Xiang Luo, Haowen Lin, Jiahui Huang, Baixin Lin, Fangfang Huang, Hui Luo
Risk factors and prognostic nomogram for patients with second primary cancers after lung cancer using classical statistics and machine learning. Clinical and experimental medicine (2022)
Yuqi Lin, Jiajia Yang, Lian-Xiang Luo, Xiaoyong Zhang, Shengyu Deng, Xiaodan Chen, Yiyang Li, Alaa El-Din Ahmed Bekhit, Baojun Xu, Riming Huang
Ferroptosis Related Immunomodulatory Effect of a Novel Extracellular Polysaccharides from Marine Fungus Aureobasidium melanogenum . Marine drugs 20 (5) (2022)
Fangfang Huang, Jinjin Yu, Tianwen Lai, Lian-Xiang Luo, Weizhen Zhang
The Combination of Bioinformatics Analysis and Untargeted Metabolomics Reveals Potential Biomarkers and Key Metabolic Pathways in Asthma. Metabolites 13 (1) (2022)
Lian-Xiang Luo, Xinyue Yao, Jing Xiang
Pyroptosis-Related Gene Model Predicts Prognosis and Immune Microenvironment for Non-Small-Cell Lung Cancer. Oxidative medicine and cellular longevity 2022 (2022)
Rui Li, Qing-Ling Zhou, Shu-Tong Chen, Min-Rui Tai, Hong-Ying Cai, Rui Ding, Xiao-Fei Liu, Jian-Ping Chen, Lian-Xiang Luo, Sai-Yi Zhong
Chemical Characterization and Immunomodulatory Activity of Fucoidan from Sargassum hemiphyllum . Marine drugs 21 (1) (2022)
Yinglin Liao, Peng Cao, Lian-Xiang Luo
Identification of Novel Arachidonic Acid 15-Lipoxygenase Inhibitors Based on the Bayesian Classifier Model and Computer-Aided High-Throughput Virtual Screening. Pharmaceuticals (Basel, Switzerland) 15 (11) (2022)
Rui Li, Qing-Ling Zhou, Shu-Tong Chen, Min-Rui Tai, Hong-Ying Cai, Rui Ding, Xiao-Fei Liu, Jian-Ping Chen, Lian-Xiang Luo, Sai-Yi Zhong
Chemical Characterization and Immunomodulatory Activity of Fucoidan from Sargassum hemiphyllum . Marine drugs 21 (1) (2022)
Rui Li, Qing-Ling Zhou, Shu-Tong Chen, Min-Rui Tai, Hong-Ying Cai, Rui Ding, Xiao-Fei Liu, Jian-Ping Chen, Lian-Xiang Luo, Sai-Yi Zhong
Chemical Characterization and Immunomodulatory Activity of Fucoidan from Sargassum hemiphyllum . Marine drugs 21 (1) (2022)
Fangfang Huang, Jinjin Yu, Tianwen Lai, Lian-Xiang Luo, Weizhen Zhang
The Combination of Bioinformatics Analysis and Untargeted Metabolomics Reveals Potential Biomarkers and Key Metabolic Pathways in Asthma. Metabolites 13 (1) (2022)
Lian-Xiang Luo, Zhentao Zhang, Yanmin Weng, Jiayan Zeng
Ferroptosis-Related Gene GCLC Is a Novel Prognostic Molecular and Correlates with Immune Infiltrates in Lung Adenocarcinoma. Cells 11 (21) (2022)
Lian-Xiang Luo, Qu Wang, Yinglin Liao
The Inhibitors of CDK4/6 from a Library of Marine Compound Database: A Pharmacophore, ADMET, Molecular Docking and Molecular Dynamics Study. Marine drugs 20 (5) (2022)
Lian-Xiang Luo, Guangxiang Xu
Fascaplysin Induces Apoptosis and Ferroptosis, and Enhances Anti-PD-1 Immunotherapy in Non-Small Cell Lung Cancer (NSCLC) by Promoting PD-L1 Expression. International journal of molecular sciences 23 (22) (2022)
Lian-Xiang Luo, Tongyu Zheng, Qu Wang, Yingling Liao, Xiaoqi Zheng, Ai Zhong, Zunnan Huang, Hui Luo
Virtual Screening Based on Machine Learning Explores Mangrove Natural Products as KRAS G12C Inhibitors. Pharmaceuticals (Basel, Switzerland) 15 (5) (2022)
Lian-Xiang Luo, Manshan Li, Jiating Su, Xinyue Yao, Hui Luo
FURIN correlated with immune infiltration serves as a potential biomarker in SARS-CoV-2 infection-related lung adenocarcinoma. Clinical and experimental medicine (2021)
Lian-Xiang Luo, Ai Zhong, Qu Wang, Tongyu Zheng
Structure-Based Pharmacophore Modeling, Virtual Screening, Molecular Docking, ADMET, and Molecular Dynamics (MD) Simulation of Potential Inhibitors of PD-L1 from the Library of Marine Natural Products. Marine drugs 20 (1) (2021)
Lian-Xiang Luo, Yushi Zheng, Zhiping Lin, Xiaodi Li, Xiaoling Li, Mingyue Li, Liao Cui, Hui Luo
Identification of SHMT2 as a Potential Prognostic Biomarker and Correlating with Immune Infiltrates in Lung Adenocarcinoma. Journal of immunology research 2021 (2021)
Jian Cai, Chunmei Chen, Yanhui Tan, Weihao Chen, Xiao-Wei Luo, Lian-Xiang Luo, Bin Yang, Yonghong Liu, Xue-Feng Zhou
Bioactive Polyketide and Diketopiperazine Derivatives from the Mangrove-Sediment-Derived Fungus Aspergillus sp. SCSIO41407. Molecules (Basel, Switzerland) 26 (16) (2021)
Fangfang Huang, Yushi Zheng, Xiaoling Li, Hui Luo, Lian-Xiang Luo
Ferroptosis-related gene AKR1C1 predicts the prognosis of non-small cell lung cancer. Cancer cell international 21 (1) (2021)
Lian-Xiang Luo, Jiating Su, Yushi Zheng, Fangfang Huang, Riming Huang, Hui Luo
SLC2A5 Correlated with Immune Infiltration: A Candidate Diagnostic and Prognostic Biomarker for Lung Adenocarcinoma. Journal of immunology research 2021 (2021)
Xiaoqi Zheng, Tongyu Zheng, Yinglin Liao, Lian-Xiang Luo
Identification of Potential Inhibitors of MurD Enzyme of Staphylococcus aureus from a Marine Natural Product Library. Molecules (Basel, Switzerland) 26 (21) (2021)
Xiaoling Li, Riming Huang, Mingyue Li, Zheng Zhu, Zhiyan Chen, Liao Cui, Hui Luo, Lian-Xiang Luo
Parthenolide inhibits the growth of non-small cell lung cancer by targeting epidermal growth factor receptor. Cancer cell international 20 (1) (2020)
Elaine Lai-Han Leung, Lian-Xiang Luo, Ying Li, Zhong-Qiu Liu, Lan Lan Li, Dan Feng Shi, Ying Xie, Min Huang, Lin Lin Lu, Fu Gang Duan, Ju Min Huang, Xing Xing Fan, Zhong Wen Yuan, Jian Ding, Xiao Jun Yao, David C Ward, Liang Liu
Identification of a new inhibitor of KRAS-PDEδ interaction targeting KRAS mutant nonsmall cell lung cancer. International journal of cancer 145 (5) (2019)